Analysis of the inhibition of PAI-1 by metal theaflavin complexes and their degradation products

Author： Jankun Jerzy Kondray Victor Skrzypczak-Jankun Ewa

ISSN： 1107-3756

Source： International Journal of Molecular Medicine, Vol.31, Iss.5, 2013-05, pp. : 1153-1158

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PAI-1 inhibition and obesity: structural complexities and biological hurdles

By Crandall David L

Future Lipidology, Vol. 2, Iss. 1, 2007-02 ,pp. : 5-8

Future Medicine

Access to resources Recommend Favorite

Recombinant PAI‐1 therapy restores myoendothelial junctions and erectile function in PAI‐1‐deficient mice

ANDROLOGIA (ELECTRONIC), Vol. 47, Iss. 10, 2015-12 ,pp. : 1147-1152

John Wiley & Sons Inc

Access to resources Recommend Favorite

PAI-1 Promoter Polymorphism Modulates uPA-PAI Complex Accumulation by Breast Cancer Cells

Oncology, Vol. 62, Iss. 3, 2002-06 ,pp. : 286-290

Karger

Access to resources Recommend Favorite

STATUS OF FIBRIN DEGRADATION PRODUCTS IN LEPROSY

THE JOURNAL OF DERMATOLOGY, Vol. 11, Iss. 6, 1984-12 ,pp. : 545-549

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation of low PAI‐1 activity as a risk factor for hemorrhagic diathesis

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 4, Iss. 1, 2006-01 ,pp. : 201-208

John Wiley & Sons Inc

Access to resources Recommend Favorite